FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1601227546> ?p ?o ?g. }

• W1601227546 endingPage "536" @default.
• W1601227546 startingPage "522" @default.
• W1601227546 abstract "Sixty-two children with acute rheumatic fever were treated with either ACTH, cortisone, salicylates or bed rest alone. Data concerning the effect on acute symptoms and follow-up observations of residual cardiac murmurs are presented. In addition, similar follow-up data on 18 previously-reported patients treated with ACTH are presented. Joint symptoms responded somewhat more rapidly to ACTH or cortisone than to salicylates, but an impressive response occurred to all of the drugs. Fever subsided within a few hours to 2 days in almost all individuals treated with any of these drugs. Elevated erythrocyte sedimentation rates returned to normal much more rapidly in the ACTH (mean 16 days) and cortisone (mean, 12 days) groups than in the salicylate (mean, 43 days) or bed-rest (mean, 48 days) groups. Although laboratory evidence of rebound in the form of an elevation of erythrocyte sedimentation rate occurred in 52 per cent of patients in the hormone-treated groups upon reduction or withdrawal of therapy, clinical evidence of rebound was rare in these groups but relatively common among the salicylate-treated patients. After follow-up periods as long as 3 9/12 years, residual cardiac murmurs were rare in the hormone-treated patients as compared to those treated with salicylates or with bed rest alone. Three years after discharge from the hospital, 6 per cent of the hormone-treated patients and 82 per cent of those not treated with hormones had residual cardiac murmurs. Moreover, the appearance of new murmurs following discharge was rare in the hormone groups and the murmurs which appeared were not persistent. New, persistent murmurs were noted relatively commonly following treatment with salicylates or bed rest alone. The importance of adequate dosage and individualization in therapy of rheumatic fever with ACTH and cortisone is stressed. The conclusions drawn are: the optimal initial doses of ACTH and cortisone are at least 1 I.U. and 3 mg. per pound per day, respectively; the initial daily dose should be continued until all laboratory and clinical evidence of rheumatic activity has disappeared; and then therapy should be decreased gradually but only if the patient shows no evidence of reactivation of rheumatic fever." @default.
• W1601227546 created "2016-06-24" @default.
• W1601227546 creator A5009967639 @default.
• W1601227546 creator A5041926561 @default.
• W1601227546 creator A5046712657 @default.
• W1601227546 creator A5075129485 @default.
• W1601227546 creator A5083680245 @default.
• W1601227546 date "1955-05-01" @default.
• W1601227546 modified "2023-09-27" @default.
• W1601227546 title "THERAPY OF ACUTE RHEUMATIC FEVER" @default.
• W1601227546 doi "https://doi.org/10.1542/peds.15.5.522" @default.
• W1601227546 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14370887" @default.
• W1601227546 hasPublicationYear "1955" @default.
• W1601227546 type Work @default.
• W1601227546 sameAs 1601227546 @default.
• W1601227546 citedByCount "17" @default.
• W1601227546 countsByYear W16012275462012 @default.
• W1601227546 countsByYear W16012275462015 @default.
• W1601227546 crossrefType "journal-article" @default.
• W1601227546 hasAuthorship W1601227546A5009967639 @default.
• W1601227546 hasAuthorship W1601227546A5041926561 @default.
• W1601227546 hasAuthorship W1601227546A5046712657 @default.
• W1601227546 hasAuthorship W1601227546A5075129485 @default.
• W1601227546 hasAuthorship W1601227546A5083680245 @default.
• W1601227546 hasConcept C121608353 @default.
• W1601227546 hasConcept C126322002 @default.
• W1601227546 hasConcept C141071460 @default.
• W1601227546 hasConcept C164705383 @default.
• W1601227546 hasConcept C2777854218 @default.
• W1601227546 hasConcept C2778143017 @default.
• W1601227546 hasConcept C2780275930 @default.
• W1601227546 hasConcept C2780484280 @default.
• W1601227546 hasConcept C2781236483 @default.
• W1601227546 hasConcept C530470458 @default.
• W1601227546 hasConcept C71315377 @default.
• W1601227546 hasConcept C71924100 @default.
• W1601227546 hasConcept C90924648 @default.
• W1601227546 hasConceptScore W1601227546C121608353 @default.
• W1601227546 hasConceptScore W1601227546C126322002 @default.
• W1601227546 hasConceptScore W1601227546C141071460 @default.
• W1601227546 hasConceptScore W1601227546C164705383 @default.
• W1601227546 hasConceptScore W1601227546C2777854218 @default.
• W1601227546 hasConceptScore W1601227546C2778143017 @default.
• W1601227546 hasConceptScore W1601227546C2780275930 @default.
• W1601227546 hasConceptScore W1601227546C2780484280 @default.
• W1601227546 hasConceptScore W1601227546C2781236483 @default.
• W1601227546 hasConceptScore W1601227546C530470458 @default.
• W1601227546 hasConceptScore W1601227546C71315377 @default.
• W1601227546 hasConceptScore W1601227546C71924100 @default.
• W1601227546 hasConceptScore W1601227546C90924648 @default.
• W1601227546 hasIssue "5" @default.
• W1601227546 hasLocation W16012275461 @default.
• W1601227546 hasLocation W16012275462 @default.
• W1601227546 hasOpenAccess W1601227546 @default.
• W1601227546 hasPrimaryLocation W16012275461 @default.
• W1601227546 hasRelatedWork W1569917038 @default.
• W1601227546 hasRelatedWork W1601227546 @default.
• W1601227546 hasRelatedWork W1905694387 @default.
• W1601227546 hasRelatedWork W1994443194 @default.
• W1601227546 hasRelatedWork W2009567661 @default.
• W1601227546 hasRelatedWork W2039266297 @default.
• W1601227546 hasRelatedWork W2047967234 @default.
• W1601227546 hasRelatedWork W2318867743 @default.
• W1601227546 hasRelatedWork W2397710375 @default.
• W1601227546 hasRelatedWork W2439875401 @default.
• W1601227546 hasVolume "15" @default.
• W1601227546 isParatext "false" @default.
• W1601227546 isRetracted "false" @default.
• W1601227546 magId "1601227546" @default.
• W1601227546 workType "article" @default.